Zaroxolyn (metolazone)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Metolazone, which is structurally and pharmacologically similar to thiazides, is a diuretic and antihypertensive agent.
Metolazone shares the uses of the thiazide diuretics; however, there is some evidence that metolazone may be more effective than other thiazide-like diuretics in the management of edema in patients with impaired renal function.
Generic name: metolazone
Pronunciation: (me-TOLE-a-zone)
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Zaroxolyn
Indications
The following indications are listed for Zaroxolyn:
- Hypertension
- Peripheral Edema Due To Chronic Heart Failure
- Pulmonary Edema Due To Chronic Heart Failure
- Renal Disease With Edema
Also known as: Edema Associated With Renal Insufficiency, Elevated Blood Pressure, Essential Hypertension, Hyperpiesia, Hyperpiesis, Hypertensive Disorder, Peripheral Edema Due To Chf, Peripheral Edema Due To Congestive Heart Failure, Pulmonary Edema Due To Congestive Heart Failure, Systemic Arterial Hypertension.
Dosing
Dosage of metolazone depends on the specific formulation used and condition being treated and should be individualized according to the patient's requirements and response. Mykrox(R) tablets (no longer commercially available in the US) were more rapidly and extensively absorbed than other metolazone formulations and were not therapeutically equivalent to Zaroxolyn(R) or other formulations of the drug that share the latter's slower and incomplete absorption. Mykrox(R) and bioequivalent formulations should not be interchanged with Zaroxolyn(R) and bioequivalent formulations. If metolazone is added to the regimen of a patient stabilized on a potent hypotensive agent, the dosage of the hypotensive agent should initially be reduced to avoid the possibility of severe hypotension.
Metolazone is administered orally.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
There are no severe adverse reactions for this drug.
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.